Navigation Links
Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial
Date:1/16/2012

esult, readers are cautioned not to place undue reliance on any of our forward-looking statements. 

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and future business decisions made by us and our competitors.  All of these factors are difficult or impossible to predict accurately and many of them are beyond our control.  For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A – Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A – Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file hereafter.  We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements.  This cautionary statement is applicable to all forward-looking statements contained in this document.CONTACT:Eric Olson 

336-293-4393 (office) 

Media Relations 

Boston Scientific Corporation 

eric.olson@bsci.com 

  

Sean Findlen 

617-520-7268  (office) 

Media Relations 

Weber Shandwick 

sfindlen@webershandwick.com  

  

Sean Wirtjes 

508-652-5305 (office) 

Investor Relations&
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. Boston University Biomedical Engineers Find Chink in Bacterias Armor
4. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
5. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
8. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
9. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
10. Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
11. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... March 5, 2015  Medical Diagnostic Laboratories, L.L.C., ... high complexity, state-of-the-art, automated DNA-based molecular analyses, announces ... (HPV) testing which utilizes cutting edge technology, including ... year, approximately 12,000 women are diagnosed with cervical ... . Genital Human Papillomaviruses (HPV) are a group ...
(Date:3/5/2015)... , March 5, 2015  Relmada Therapeutics, ... therapies for the treatment of chronic pain, today ... researchers to advisory roles. The panel of experts ... programs and efforts to advance the company pipeline ... They bring expertise in a range of areas ...
(Date:3/5/2015)... 5, 2015  Celsion Corporation (NASDAQ: ... host a conference call to discuss year-end 2014 ... development programs for ThermoDox®, its proprietary heat-activated liposomal ... platforms, TheraPlas™ and TheraSilence™, in immunotherapy and RNA ... 12, 2015. To participate in the call, interested ...
Breaking Medicine Technology:Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 2Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 2Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 4Celsion Corporation to Hold Year-End 2014 Financial Results Conference Call on Thursday, March 12, 2015 2
... HARRISBURG, Pa., Nov. 20 The Department of Health today began providing ... have previous access to the vaccine. , A total of 18 clinics ... 2 p.m. to 8 p.m. Hours on Saturday, Nov. 21, will be ... operate from 2 p.m. to 8 p.m. , Individuals in the ...
... ... Reportlinker.com announces that a new market research ... Global Self Monitoring Blood Glucose Market ... , http://www.reportlinker.com/p0164657/Global-Self-Monitoring-Blood-Glucose-Market-(SMBG )-Increasing-Adoption-to-Drive-Growth.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire , ...
Cached Medicine Technology:Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available 2Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 2Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 3Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 4Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 5Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 6Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 7Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 8
(Date:3/5/2015)... The global digital PCR (dPCR) and qPCR market is expected to ... to 2019. , The global digital PCR (dPCR) and qPCR market ... to 2019. Although the mature markets such as the U.S., Germany, ... and qPCR market the Asia-Pacific region is expected to grow at ... of the digital PCR (dPCR) and qPCR market is driven by ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 This ... formaldehyde in low-cost laminate flooring products, initiating ... manufacturer of eco-friendly building materials made primarily from ... by testing all their flooring products for volatile ... laboratory Benchmark International (BMH). Results from ...
(Date:3/5/2015)... AxoGen, Inc. (NASDAQ: AXGN) , a leading ... market, reported record revenue of $4.79 million for the ... million in the year-ago fourth quarter demonstrating the Company’s ... strong fourth quarter revenue growth reflects the market’s growing ... driving increased surgeon adoption of our unique product portfolio ...
(Date:3/5/2015)... New York, New York (PRWEB) March 05, 2015 ... behalf of men who allegedly suffered heart attacks, strokes ... of prescription low testosterone therapies continue to move forward ... District Court, Northern District of Illinois. According to a ... has set forth procedures for the use of master ...
(Date:3/5/2015)... RI (PRWEB) March 05, 2015 Rhode Island ... third year in a row to support the Providence College ... The donation covered the purchase of the ‘Think Pink’ uniforms, ... against Big East Conference opponent DePaul University at Alumni Hall/Mullaney ... to continue our support of the PC women’s basketball’s ‘Pink ...
Breaking Medicine News(10 mins):Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 2Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 3Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 4Health News:With Homeowners Concerned About Formaldehyde, Cali Bamboo Puts Safety Above Bottom Line 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 4Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 2Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 3Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 4Health News:RIMI Teams Up with PC Women’s Basketball in the Fight Against Breast Cancer 2
... test of the first vaccine against hepatitis E, a form ... spread// to soldiers or other Western visitors to the region. ... an engineered virus, was 96 percent effective for Nepalese Army ... widespread even in a group without the vaccine: only 7 ...
... in an online medical training system has caused chaos ... British Medical Association has criticized//his electronic procedure of hiring ... jobless. ,The Medical Training Application Service was ... post of specialist trainee. The deadline for the receipt ...
... if consumed in moderate quantities is expected to aid in ... called as the Zutphen Study.// ,According to this ... cardiovascular deaths and increase the life span in middle aged ... the first time that a specific genre of alcohol is ...
... cancer have a slightly better long-term side effects profile ... to a study.// ,Doctors in France conducted ... stage prostate cancer to evaluate a man’s quality of ... based on the type of treatment the patient received: ...
... out with findings that encourage better care of our mouths, ... ,American and British researchers have combined study results ... blood flow through the arteries and heart, and thereby prevent ... developed nations. ,The work of these scientists has ...
... for Japanese patients looking for organ transplantation.// ... foreign patients in Chinese hospitals, more people, frustrated with ... receiving transplants in their homeland are turning to the ... ,Kenichi Hokamura, 63, of the southern Japanese ...
Cached Medicine News:Health News:Prostate Brachytherapy Causes Fewer Side Effects Than Surgery 2Health News:Good Oral Health Equals Good Health for Your Heart 2
... Estriol (E3) is one of the 3 ... estradiol and estrone). In terms of estrogenic ... estradiol [1]. Estriol is produced almost exclusively ... produced in the normal human fetus. During ...
... Estrone Sulfate (E1S) is the most abundant ... as normal men [1,2]. Estrone Sulfate is ... and has a longer half-life in blood ... generally parallel those of estrone and estradiol, ...
Helmer's Horizon Series line of refrigerators are designed specifically for the cost conscious buyer. This line offers outstanding performance, quality, and the features you need to ensure the safety...
... the i.Series refrigerator iB120, ... for the blood bank. ... than ever before, i.Series ... at the forefront of ...
Medicine Products: